Sakar Healthcare Limited (NSE:SAKAR)
India
· Delayed Price · Currency is INR 292.00
+22.95 (8.53%)
May 9, 2025, 3:30 PM IST
Sakar Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,704 | 1,534 | 1,334 | 1,282 | 947.39 | 829.8 | Upgrade
|
| Other Revenue | 8.16 | 8.16 | 8.33 | 8.91 | 5.72 | 9.34 | Upgrade
|
| Revenue | 1,712 | 1,542 | 1,342 | 1,291 | 953.12 | 839.14 | Upgrade
|
| Revenue Growth (YoY) | 12.81% | 14.89% | 3.93% | 35.47% | 13.58% | 21.95% | Upgrade
|
| Cost of Revenue | 930.41 | 842.09 | 737.45 | 748.77 | 514.6 | 437.44 | Upgrade
|
| Gross Profit | 781.77 | 699.59 | 604.47 | 542.41 | 438.52 | 401.7 | Upgrade
|
| Selling, General & Admin | 210.34 | 198.62 | 169.35 | 153.55 | 132.82 | 122.58 | Upgrade
|
| Other Operating Expenses | 111.56 | 106.73 | 94.1 | 85.81 | 73.86 | 72.28 | Upgrade
|
| Operating Expenses | 524.6 | 485.85 | 413.3 | 336.04 | 287.26 | 265.66 | Upgrade
|
| Operating Income | 257.17 | 213.73 | 191.17 | 206.38 | 151.26 | 136.04 | Upgrade
|
| Interest Expense | -55.72 | -67.45 | -54.88 | -25.88 | -23.34 | -21.12 | Upgrade
|
| Interest & Investment Income | 1.25 | 1.25 | 3.93 | 0.56 | 0.16 | 0.14 | Upgrade
|
| Currency Exchange Gain (Loss) | 17.23 | 17.23 | 34.49 | 11.62 | 5.85 | 8.67 | Upgrade
|
| Other Non Operating Income (Expenses) | -21.5 | -8.71 | -4.75 | -3.22 | -1.61 | -1.47 | Upgrade
|
| EBT Excluding Unusual Items | 198.43 | 156.06 | 169.96 | 189.46 | 132.33 | 122.27 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.94 | 2.94 | - | 0.62 | - | - | Upgrade
|
| Other Unusual Items | -0.51 | - | -0.05 | - | - | - | Upgrade
|
| Pretax Income | 200.86 | 159 | 169.91 | 190.08 | 132.33 | 122.27 | Upgrade
|
| Income Tax Expense | 52.24 | 42.29 | 42.33 | 37.65 | 25.5 | 26.04 | Upgrade
|
| Net Income | 148.62 | 116.71 | 127.59 | 152.43 | 106.83 | 96.23 | Upgrade
|
| Net Income to Common | 148.62 | 116.71 | 127.59 | 152.43 | 106.83 | 96.23 | Upgrade
|
| Net Income Growth | 19.15% | -8.53% | -16.30% | 42.69% | 11.01% | 43.78% | Upgrade
|
| Shares Outstanding (Basic) | 22 | 21 | 19 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 21 | 19 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 8.19% | 10.39% | 23.33% | - | 0.77% | 10.12% | Upgrade
|
| EPS (Basic) | 6.85 | 5.69 | 6.86 | 10.11 | 7.09 | 6.43 | Upgrade
|
| EPS (Diluted) | 6.85 | 5.69 | 6.86 | 10.11 | 7.09 | 6.43 | Upgrade
|
| EPS Growth | 10.13% | -17.14% | -32.13% | 42.69% | 10.17% | 30.56% | Upgrade
|
| Free Cash Flow | - | -350.93 | -488.51 | -109.08 | -209.69 | 58.85 | Upgrade
|
| Free Cash Flow Per Share | - | -17.10 | -26.27 | -7.24 | -13.91 | 3.93 | Upgrade
|
| Gross Margin | 45.66% | 45.38% | 45.05% | 42.01% | 46.01% | 47.87% | Upgrade
|
| Operating Margin | 15.02% | 13.86% | 14.25% | 15.98% | 15.87% | 16.21% | Upgrade
|
| Profit Margin | 8.68% | 7.57% | 9.51% | 11.80% | 11.21% | 11.47% | Upgrade
|
| Free Cash Flow Margin | - | -22.76% | -36.40% | -8.45% | -22.00% | 7.01% | Upgrade
|
| EBITDA | 458.96 | 393.27 | 341.03 | 279.66 | 206.34 | 206.84 | Upgrade
|
| EBITDA Margin | 26.81% | 25.51% | 25.41% | 21.66% | 21.65% | 24.65% | Upgrade
|
| D&A For EBITDA | 201.79 | 179.54 | 149.86 | 73.28 | 55.08 | 70.8 | Upgrade
|
| EBIT | 257.17 | 213.73 | 191.17 | 206.38 | 151.26 | 136.04 | Upgrade
|
| EBIT Margin | 15.02% | 13.86% | 14.25% | 15.98% | 15.87% | 16.21% | Upgrade
|
| Effective Tax Rate | 26.01% | 26.60% | 24.91% | 19.81% | 19.27% | 21.30% | Upgrade
|
| Revenue as Reported | 1,723 | 1,565 | 1,380 | 1,304 | 959.15 | 849.97 | Upgrade
|
| Advertising Expenses | - | 0.07 | 0.28 | 0.22 | 0.06 | 0.02 | Upgrade
|
Updated Feb 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.